Unfolding of sickle cell trait by coronavirus disease 2019 (COVID-19) infection

Br J Haematol. 2020 Oct;191(2):e38-e40. doi: 10.1111/bjh.17089. Epub 2020 Sep 23.
No abstract available

Keywords: COVID-19; sickle cell disease; vaso-occlusive crisis.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Anticoagulants / therapeutic use
  • Azithromycin / therapeutic use
  • COVID-19 / blood
  • COVID-19 / complications*
  • COVID-19 / therapy
  • COVID-19 Drug Treatment
  • Combined Modality Therapy
  • Delayed Diagnosis
  • Diagnostic Errors
  • Erythrocyte Transfusion
  • Female
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Immunocompromised Host
  • Osteonecrosis / diagnostic imaging
  • Osteonecrosis / etiology
  • Oxygen Inhalation Therapy
  • Rheumatic Fever / diagnosis
  • SARS-CoV-2*
  • Sickle Cell Trait / blood
  • Sickle Cell Trait / complications
  • Sickle Cell Trait / diagnosis*
  • Sickle Cell Trait / immunology
  • Splenectomy / adverse effects
  • Superinfection
  • Tachycardia / etiology
  • Thrombocytopenia / etiology
  • Young Adult

Substances

  • Adrenal Cortex Hormones
  • Anticoagulants
  • Hydroxychloroquine
  • Azithromycin